Daily News Podcast

Shifting Part B to D: Who saves?


 

A shift in Medicare drug coverage from Part B to Part D might save the government money, but might cost patients. Also today, there’s no single treatment for fibromyalgia, obesity-related cancers are increasing in younger adults, and pregnancy problems predict cardiovascular future.

Amazon Alexa

Apple Podcasts

Google Podcasts

Spotify

Recommended Reading

Decreased insulin clearance and insulin resistance
MDedge Endocrinology
AHA reports statins are safe
MDedge Endocrinology
ACA in peril after Texas ruling
MDedge Endocrinology
Ray Barfield Part II: Philosophy and Medicine
MDedge Endocrinology
Dermatologic comorbidities of atopic dermatitis
MDedge Endocrinology
Breast cancer study: No link between soy, all-cause mortality
MDedge Endocrinology
Courts stop contraceptive mandate
MDedge Endocrinology
The effects of delayed contraception
MDedge Endocrinology
PCSK9 inhibition isn’t the answer for high Lp(a)
MDedge Endocrinology
Podcasting, burnout, oncology: Dr. David Henry
MDedge Endocrinology